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Abstract
Background: The Democratic Republic of Congo (DRC) has a significant burden of lymphatic filariasis (LF) caused
by the parasite Wuchereria bancrofti. A major impediment to the expansion of the LF elimination programme is the
risk of serious adverse events (SAEs) associated with the use of ivermectin in areas co-endemic for onchocerciasis
and loiasis. It is important to analyse these and other factors, such as soil transmitted helminths (STH) and malaria
co-endemicity, which will impact on LF elimination.
Results: We analysed maps of onchocerciasis community-directed treatment with ivermectin (CDTi) from the
African Programme for Onchocerciasis Control (APOC); maps of predicted prevalence of Loa loa; planned STH
control maps of albendazole (and mebendazole) from the Global Atlas of Helminth Infections (GAHI); and bed nets
and insecticide treated nets (ITNs) distribution from Demographic and Health Surveys (DHS) as well as published
historic data which were incorporated into overlay maps. We developed an approach we designate as micro-
stratification overlap mapping (MOM) to identify areas that will assist the implementation of LF elimination in the
DRC. The historic data on LF was found through an extensive review of the literature as no recently published
information was available.
Conclusions: This paper identifies an approach that takes account of the various factors that will influence not
only country strategies, but suggests that country plans will require a finer resolution mapping than usual, before
implementation of LF activities can be efficiently deployed. This is because 1) distribution of ivermectin through
APOC projects will already have had an impact of LF intensity and prevalence 2) DRC has been up scaling bed net
distribution which will impact over time on transmission of W. bancrofti and 3) recently available predictive maps
of L. loa allow higher risk areas to be identified, which allow LF implementation to be initiated with reduced risk
where L. loa is considered non-endemic. We believe that using the proposed MOM approach is essential for
planning the expanded distribution of drugs for LF programmes in countries co-endemic for filarial infections.
Background
T h eD e m o c r a t i cR e p u b l i co fC o n g o( D R C )i st h el a r g e s t
lymphatic filariasis (LF) endemic country in Africa with
over 49 million people at risk [1-3]. The challenge of
mapping LF in the 2.3 m sq km of inhabited regions is
further compounded by co-endemicity with Loa loa and
the poor road infrastructure in the post-conflict environ-
ment [1]. Delimiting L. loa endemic areas using a high
resolution mapping strategy, is critical in minimising the
risk for severe adverse events (SAEs) associated with
mass drug administration (MDA) with ivermectin.
Nevertheless, scaling up treatment for soil transmitted
helminths (STH) with albendazole and widespread distri-
bution of long-lasting insecticidal treated nets (LLINs)
will positively impact LF endemicity. Incorporating these
factors into an overlap mapping strategy will constitute a
valuable prerequisite for LF control and surveillance.
The Global Programme to Eliminate Lymphatic Filaria-
sis (GPELF) initiated in 2000 aims to eliminate the disease
as a public health problem by the year 2020. The recent
publication of the Progress Report detailing the successes
of the programme to date have been recorded, as well as,
the Strategic Plan for the next decade of activities [1]. The
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MDA using annual treatment with the drugs ivermectin
and albendazole in countries in Africa co-endemic with
onchocerciasis, and elsewhere with DEC and albendazole.
Africa has a significant burden of LF caused by the para-
site Wuchereria bancrofti with 35 endemic countries, and
a further 6 countries where the process of the verification
of the absence of transmission is underway [1-3].
While GPELF is making progress overall [1,4] with sig-
nificant economic saving being demonstrated [5], Africa
remains behind other regions with 16 countries still to
start MDA implementation. Many of these countries are
conflict/ post-conflict countries, characterised formally as
Least Developed Countries (LDCs) and are among the
poorest in the world with minimal human and financial
resources [6]. These constraints pose problems for the
national LF programmes with the potential to severely
hinder the 2020 goal of LF elimination globally. The
WHO Strategic Plan [1] identifies two priorities for the
Africa Region to achieve the expansion of MDA; first to
resolve the treatment challenges posed by the co-endemi-
city of L. loa due to concerns associated with SAEs when
treatment with ivermectin is given in onchoceriasis pro-
grammes [7,8]; second to explore how best to utilise vector
control as a supplemental intervention for interrupting
transmission, especially in filarial co-endemic areas.
The expansion of LF programmes in Africa will inevita-
bly spread into L. loa and Onchocerca volvulus endemic
areas. Due to the increased risk of SAEs, the current
MDA regime of ivermectin and albendazole is not
recommended where W.bancrofti prevalence overlaps
with L. loa, or where all three filarial parasites co-exist
unless those implementing onchocerciasis control adhere
to strict guidelines developed by the Mectizan Donation
Programme. However, recent maps on the distribution of
L. loa produced from the rapid assessment procedure for
loiasis (RAPLOA) [8-11], and of Community Directed
Treatment with ivermectin (CDTi) produced from rapid
epidemiological mapping for onchocerciasis (REMO)
[8,12] help identify high risk areas that may require fine
scale mapping and/or alternative intervention strategies.
Importantly, the recent L. loa and CDTi distribution
maps will also highlight the potential synergies and bene-
fits between the LF elimination and onchocerciasis con-
trol programmes [1,12]. For example, it has been shown
that CDTi treatment over 5-6 years with coverage of 65%
or more could significantly reduce the prevalence and
intensity of other filarial parasites, mainly W. bancrofti
even though there appeared to be little impact on the
adult worm [13,14]. Similarly, repeated doses of albenda-
zole used in STH programmes could potentially impact
on LF prevalence [15]. Conversely, the scale up of LF
elimination programmes using ivermectin and albenda-
zole across large regions of Africa could help to reinforce
the achievements made by the onchoceriasis programmes
by increasing the use of ivermectin in areas where oncho-
cerciasis was not controlled as it was previously defined
as hypo-endemic but now referred to as low transmission
areas [8]. This will assist in reducing the potential resi-
dual human reservoir population of O. volvulus that
could then cause re-infection in areas that have been
cleared of the disease. The widespread distribution of
albendazole as a component of LF programmes will also
enhance the efforts of STH programmes [16].
Additional benefits may be gained from malaria vector
control programmes, especially in Africa where the filar-
ial parasite W. bancrofti is transmitted by Anopheles spe-
cies [17,18]. Malaria is commonly controlled using
insecticide treated nets (ITNs)/LLINs, which act as baited
traps for the mosquito when a person sleeps under it
[19]. The use of ITNs/LLINs has shown to be effective in
reducing LF prevalence in a W. bancrofti - L. loa co-
endemic area in Nigeria [20], and in W. bancrofti trans-
mission areas in Kenya [21], Uganda [22] and Papua New
Guinea [23]. Currently, there are large scale malaria con-
trol programmes under way across Africa, which involve
the mass distribution of ITNs/LLINs [19]. The rapid
expansion of malaria vector control could also signifi-
cantly impact LF prevalence, and distribution maps of
ITNs/LLINs would help national LF programmes assess
their utility, especially in countries yet to start MDA and
those with L. loa endemic areas.
WHO [1] stated “Better tools are needed to assess risk
as are guidelines on criteria for including or excluding
people from treatment programmes”. This paper seeks
to address these issues by introducing the concept of
micro-stratification overlap mapping (MOM) of filarial
infections and effective interventions in Central Africa
to define more precisely where and what strategies for
LF programmes might be implemented in areas of
L. loa co-endemicity, whilst also assessing the historic
data available on LF in one of the most important coun-
tries in Africa facing this problem, the DRC.
The DRC is a priority country for GPELF since it is yet
to start MDA for LF elimination, and there are several
significant challenges for the national LF programme.
First, DRC is considered to have the second highest
population at risk of LF in Africa (est. 49, 140, 000) [1].
However, this risk is not well defined as no recent in
depth studies appear to have been carried out, and the
historic information available is largely from studies
undertaken in the pre-independence era. This data sug-
gests that the distribution of W. bancrofti is discontinu-
ous [24-26]. Second, L. loa is endemic across large
remote geographical areas, and closely associated with
dense tropical rain forests which favour the vectors Chry-
sops sp. dimidiata and silacea [9,27,28]. Third, DRC is
one of the poorest countries in the world and has been
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ades [6,29]. It is now classified as a post conflict country,
but these conflicts have left a scarcity of resources, poor
infrastructure and numerous challenges to the health
care system. Fourth, there is little vector control in place
as an alternative intervention with less than 10% of
households owning an ITN reported in 2007 [19,30,31].
These factors coupled with its sheer geographical size of
2.3 m sq km, limited transport networks and the remote-
ness of dispersed communities, present major challenges
for many health programmes.
The aim of this paper is to review and synthesise the
current knowledge of the distribution of W. bancrofti in
the DRC, and factors that will impact on the control and
elimination of LF such as loiasis co-endemicity, oncho-
cerciasis control programmes, STH deworming activities
and malaria bed net distributions. We thus introduce a
new term Micro-stratification Overlap Mapping (MOM),
which we suggest is a prerequisite for planning any future
LF programmes in countries where there is co-endemic
loiasis and indeed other control programmes which
impact on LF implementation. For this reason, MOM
needs to be widely applied when any Preventive Che-
motherapy Programme is planned given the synergistic
impact of ivermectin and albendazole used together in
LF elimination or separatelyi no n c h o c e r c i a s i so rS T H
programmes respectively and where there is bed net dis-
tribution. This information is essential to optimise the
future LF MDA implementation strategy to ensure safety,
maximum cost effectiveness as well as impact.
Methods
Study location
The DRC (formerly the Congo Free State, Belgian Congo,
Congo-Léopoldville, Congo-Kinshasa, and Zaire), is
located in Central Africa. The administrative structure
has changed since independence in 1960, and is currently
divided into 10 provinces and one major city, Kinshasa
(8.4 million), the capital city and main urban agglomer-
ate. Other major cities include Lubumbashi, Mbuji-Mayi,
Kolwezi, Kisangani and Matadi. The DRC is the second
largest country in Africa by area (approx. 2,345,409 km
2)
and the fourth most populous nation in Africa, with a
population of nearly 71 million (35% urban population)
[31,32].
T h ec o u n t r yh a sas h o r tA t l a n t i cc o a s t l i n e( 4 0k m )
encompassing the mouth of the Congo River. It straddles
the Equator, and has a tropical climate experiencing very
high precipitation (up to 2000 mm annually), which
helps sustain the Congo rainforest and the extensive
Congo River Basin that occupies nearly the entire coun-
try [33,34]. The vast central basin is a low-lying plateau,
surrounded by mountains in the east where the climate is
cooler and wetter, and mountains in the south where the
climate is cooler and drier. Dense tropical rain forest cov-
ers the central river basin and eastern highlands.
LF distribution
To review and synthesise the current knowledge of the
distribution of LF, a systematic search for data in peer-
reviewed published literature, and national reports was
carried out using PubMed, JSTOR, Google, SCOPUS and
other online scientific and historical databases. Studies
and reports with data on the prevalence of LF infection
(as measured by microfilaria, and immunochromato-
graphic card tests- ICTs), disease cases, as well as poten-
tial mosquito vectors were identified, and information on
the location (province, district, place), and time period
(month, year, decade) and prevalence was collated into a
database for mapping and descriptive analyses.
The locations were geo-referenced using administrative
boundary maps at provincial and district level, and where
specific places were reported, the latitude and longitude
coordinates were obtained from data available at the
GEOnet Names Server [35]. All data were imported into
the geographical information system software ArcGIS 9.3
(ESRI, Redlands CA) to produce historical LF and vector
distribution maps.
Loiasis co-endemicity
To examine the potential extent of LF and loiasis co-
endemicity, the recent map on the distribution of L. loa
produced from RAPLOA surveys carried out between
2004 and 2010 across DRC [9,27] was used for compari-
sons with LF distribution. The L. loa map was imported
into ArcGIS, and four levels of L.loa prevalence (< 5%, 5-
20%, 20-40% > 40%) were digitised (i.e. outlined and
shaded) based on the interpolated boundaries contained
in the map. The different levels of risk were highlighted,
specifically the areas with L.loa prevalence > 40%, which
are associated with an increased risk of SAEs.
In addition, historical maps on L.loa and Chrysops vec-
tor distributions were reviewed as they are likely to be
comparable with the LF distribution map. A systematic
search for maps and review articles in peer-reviewed
published literature, and national reports was carried out.
Maps and geo-referenced data were imported into Arc-
GIS and digitised to produce historical L.loa and vector
distribution maps for comparison with the current L.loa
distribution map, and with the historical LF distribution
maps.
Interventions (risks and benefits thereof)
Onchocerciasis control programmes
To examine the distribution of ivermectin, and the
potential risks associated with filarial co-endemicity, and
potential benefits of the onchocerciasis control pro-
gramme, the CDTi map produced from REMO surveys
Kelly-Hope et al. Parasites & Vectors 2011, 4:178
http://www.parasitesandvectors.com/content/4/1/178
Page 3 of 13carried out in 2004 and 2005 [36] was imported into Arc-
GIS. The CDTi priority areas (i.e. ivermectin treatment
areas) were digitised and areas of potential SAEs risk
highlighted by overlapping CDTi priority areas with
potential LF and high loiasis (> 40%) distributions. The
areas that could benefit from ivermectin treatment were
highlighted by overlapping CDTi priority areas with
potential LF areas and low to average loiasis (< 40%)
distributions.
Soil Transmitted Helminth (STH) planning
To examine the potential benefits of albendazole (or
mebendazole) distribution in potential LF areas, the
controlled planning map for STHs in DRC outlining
recommended intervention districts of either once yearly
mass treatment or twice yearly mass treatment [16]
were imported and digitised in ArcGIS. The maps are
based on predictive models from a small number of sur-
veys so have considerable limitations, however, they pro-
vide a guide of albendazole (or mebendazole) priority
areas for future mass treatment campaigns. Currently,
the extent of treatment for STHs across DRC is not
known. However, the areas that may or may not benefit
f r o maS T Hp r o g r a m m ew e r eh i g h l i g h t e db yo v e r l a p -
ping treatment areas with potential LF, low risk loiasis
and CDTi priority areas.
Malaria bed net distributions
To examine the potential impact of vector control on the
LF and filarial co-endemic areas, a distribution map on the
proportion of households with children under 5 years old
owning an ITN [30] produced from cluster data from a
Demographic and Health Survey (DHS) carried out in
2007 [31] was imported into ArcGIS. The map was based
on 5,524 households from 300 clusters across DRC with
ownership ranging from 0 to 72.3%. Based on a midpoint
of 35%, two levels of ITN ownership were digitised to
highlight low (< 35%) and average to high (> 35%) areas.
The DHS geo-referenced data were examined further to
determined the distribution of households owning any bed
net (untreated and/or insecticide treated) by cluster, and
to examine differences in ownership by Province [31]. The
potential risks and benefits of low (< 35%), and average to
high (> 35%) bed net and ITN ownership, were highlighted
by overlapping the digitised maps and clusters with LF and
filarial co-endemic areas.
Results
LF distribution
There are several reviews available on the distribution of
LF [24-26,37,38], which outline sero-prevalence, clinical
and entomological studies or short/case reports carried
out in DRC. In total 11 studies/reports describing LF
infection or clinical disease were identified and the main
findings are summarised in Table 1. Most studies were
carried out between the 1930s and 1970s. No study has
been published since 1974. The earliest report of LF is
from Boma in the Bas Congo Province in 1899, when
microfilaria from Filaria nocturna (W. bancrofti)w a s
found in night blood of a teenage boy [26,39].
From the limited data available, the prevalence
appears to vary within regions and across the country
(Figure 1). The review by Sasa [26], cites the absence of
W. bancrofti in night blood surveys from Pawa, Haut-
Uele Province [40], and Yakusa, Oriental Province [41],
and highlights that these authors state that W. bancrofti
was never confirmed with precision from the Congo,
and contrary to belief it was considered not to extend
across tropical Africa, including the central Congo areas
[26,42]. LF was considered not to be prevalent around
Mbandaka (Coquilhatville) [43,44] and the region of
Tshuapa (Cuvette Centrale) in Équateur Province [45],
but is reported to be widespread in northern region
close to international borders with South Sudan, Congo
Republic and Central African Republic [26,37]. The
Department of Health Data report in 1965 [46] reported
LF to be widespread with most cases from the Kasai
and Oriental Provinces, however, no specific details or
locations were provided.
The most comprehensive studies were carried out in
the Bas Congo, Bandundu and Équateur Provinces by
Henrard et al. [44], Fain et al. [45] and Fain [47]. The stu-
dies in Bas Congo Province showed that the prevalence
of W.bancrofti varied considerably, with the highest
microfilaria (mf) rates reported in villages near the
mouth and lower part of the Congo River around Boma
and Matadi (12-36%.). Lower rates were found in villages
northwards towards Thysville and Luozi (2-8%), and
around the Kinshasa region the prevalence was found to
be very low or absent (0.1%) [44]. An extensive survey in
the forested Mayombe region of Bas Congo found W.
bancrofti only in one fishing village situated in a swampy
area close to the Congo River [48] (Figure 2a).
In Bandundu Province, studies in the Idiofa and Ban-
dundu (Banningville) regions found higher W. bancrofti
mf rates in villages close to rivers, than those further
inland [44,47]. In the Bandundu region, Fain [47] exam-
ined 65 villages (2510 individuals) and found that villages
along rivers overall had 12.8% mf rates compared with
1.5% among villages more than 2 km away. There were
notable differences along and between the different rivers
(Table 1) [47], especially the Kwango, Kwilu and Kasai
Rivers as shown in Figure 2b. LF prevalence and clinical
cases, particularly hydroceles, were also reported in the
Kwango River area [49], as well as in other locations
close to the Congo River and central basin region
[50-52]. In the Tshuapa (Cuvette Central) region of
Équateur Province, very few cases were found across the
study sites and these were from two villages by the Mar-
inga River and Lomela River [45] (Figure 2c).
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Page 4 of 13Table 1 Chronological list of historical studies and reports of W.bancrofti prevalence and disease cases
Time Province Region/location Prevalence/
cases
Notes Reference(s)
1900s Bas
Congo
Boma 1 case Filaria nocturna (W. bancrofti) found in night blood from a boy Van Campenhout and
Dreypondt 1901 [39]
1930s Oriental Uele Cases Elephantiasis and hydrocele s - no W. bancrofti microfilaria detected Van den Berghe 1941 [42]
Bas
Congo
Matadi
Thysville and Luozi
Kinshasa environs
(Leopoldville)
12-36%
2-8%
0.1%
42 cases from villages around mouth/lower Congo River
1-4 cases from villages northward from mouth of Congo River
1 case from 1101 individuals examined from villages in region
Henrard et al. 1946 [44]
Kinshasa
Matadi
0.8%
3%
14 cases from 1824 hospital patients screened for infection
47 cases from 1500 hospital patients, villages close to Angola border
Hernard et al. 1946 [44]
Bandundu Idiofa
Bandundu
(Banningville)
3- 16%
3-31%
14 cases from villages along Kasai River
11 cases, most from villages along Kwango River
Henrard et al. 1946 [44]
Équateur Mbandaka
(Coquilhatville)
1-3% 3-4 cases, all considered to be from external endemic areas Henrard et al. 1946 [44].
1940s Bandundu Kwango River
Kwilu River
Inzia, Kasai and
Wamba Rivers
20%
12%
2.4 - 3.4%
Overall villages on rivers had higher mf (12.8%) rates compared with villages more than 2 km away (1.5%).
Villages along the Kwango river had the highest rates.
Fain 1947 [47]
Bandundu Kwango River Cases Clinical case examination of patients from villages along river Fain 1951 [49]
Équateur Mbandaka
(Coquilhatville)
4.8% 249 prisoners examined, cases likely from external endemic areas Chardome & Peel 1949 [43]
Orientale Yahuma, Basoko
District
46% 25 cases from 54 adult males examined in villages south of Yahuma Bellefontaine 1949 [51]
1950s Bandundu Kasongo Lunda 12 cases Typical signs detected in patients during 188 hernia operations Van Oye and Pierquin 1961
[38]
Équateur Bumba, Banzyville,
Gemena, Ikela
Reported to be widespread in northern region of province Van Oye and Pierquin 1960
[37]
1960s Oriental Lomami 63-67%
adults
9% in youths, 4% children, cases found in villages along Congo River. Hydrocele in 20% of adult males, low
prevalence of elephantiasis
Browne 1960 [50]
Kasia,
Oriental
Not specified - Disease widespread, most cases reported from Kasai and Oriental Dept of Health 1965
Équateur Tshuapa (Cuvette
Central)
0.6% 4 cases from villages on Maringa River and Lomela River, most villages examined in region were free from
disease
Fain et a.l. 1969 [45]
1970s Bas
Congo
Kimbanza, Mayubu
region
32% 18 cases from 56 people in one village close to lower Congo River, all other villages in region free of disease. Fain et al. 1974 [48]
K
e
l
l
y
-
H
o
p
e
e
t
a
l
.
P
a
r
a
s
i
t
e
s
&
V
e
c
t
o
r
s
2
0
1
1
,
4
:
1
7
8
h
t
t
p
:
/
/
w
w
w
.
p
a
r
a
s
i
t
e
s
a
n
d
v
e
c
t
o
r
s
.
c
o
m
/
c
o
n
t
e
n
t
/
4
/
1
/
1
7
8
P
a
g
e
5
o
f
1
3Only one study on the vectors of W. bancrofti in DRC
was found in the literature. This study was carried out
by Henrard et al. [44] in Bas Congo in the 1930s. The
Anopheles funestus was reported to be the most abun-
dant and principal vector in the Matadi and Songololo
region with mosquito dissections frequently showing
mature larvae, and infection rates up to 4.8%. In the
Kinshasa area, Anopheles gambaie was considered to be
a potential vector, however, Culex quinquefasciatus
(Culex fatigans), which was abundant, as to be expected
in urban settings, was considered a poor vector [25,44].
Loiasis co-endemicity
A map on the historical distribution of L.loa in the DRC
was produced primarily from maps and data in reviews
published the 1960s [28,37,38]. Most data were from
studies carried out during the 1930s and 1940s, with
additional sites mapped from studies carried out there-
after [26,52]. Figure 3a shows the areas considered to
have high prevalence, low to average prevalence, loca-
lised cases or no report cases i.e. non-endemic. The
highest L.loa infections were associated with tropical
forest zones and reported in the Mayombe region of Bas
High prevalence  / endemicity
Localised cases
LF reported, location not specified
No reports / unverified /  considered free of disease
Congo River and  tributaries
Oriental 
Equatuer
Bandundu
Kasai-
Occidental
Kasai-
Oriental 
Sud-
Kivu 
Nord-
Kivu 
Katanga
Kinshasa
Bas Congo
Maniema
Figure 1 Historical distribution of reported and suspected/potential W. bancrofti prevalence.
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districts of Oriental Province [25,26,28,37,38]. The pre-
valence in the southern and western provinces was
found to be average to low, with some localised foci.
The disease was not reported from Katanga and consid-
ered to be non-endemic.
The modified map on the current distribution of L.loa
in the DRC based on the RAPLOA surveys carried out
between 2004 and 2010 [9] is shown in Figure 3b. The
areas with L. loa prevalence > 40% are highlighted to
clearly identify areas with an increased risk of SAEs.
Similar to the historical map in Figure 3a, the highest
rates of infection occurred in the Mayombe region of Bas
Congo Province, and in Bas-Uele and Haut-Uele districts
of Oriental Province. Additional high risk areas were
identified in Maniema Province and the northern region
of Équateur Province. Average to low prevalence rates
were found in other provinces, and large areas through
the central region of the country and in Katanga Province
had low i.e. < 5% or no infection.
The distribution of Chrysops sp in DRC was most
recently reviewed by Fain [28] in the late 1960s. The spe-
cies C. silacea and C. dimidiata were identified as the
main L. loa vectors from collections across the country
between 1909 and 1968. In total, C. silacea were identi-
fied from 52 locations, and C. dimidiata from 26 loca-
tions, predominantly from the Bas Congo and Oriental
Provinces, as shown in the map produced from the avail-
able geographical coordinates (Figure 3c). The C. silacea
and C. dimidiata map was overlaid on the current L.loa
distribution to determine their concordance. Figure 3d
shows that most vectors were collected in areas of high
i.e. > 40%, or medium i.e. 20-40% prevalence.
The examination of LF and L. loa co-endemicity was
limited due to the lack of detail and geographical extent
of data available. Overall, the LF map and data indicate
a) Mayombe, Bas Congo
c) Tshuapa (Cuvette Centrale), Equateur
b) Bandundu (Banningville), Bandundu
Matadi
Mbandaka
Bandundu
KwangoRiver
Kasai River
Congo River
Congo River
Lopori River
Maringa River
Tshuapa River
Momboyo River
W. bancrofti
L. loa
O. volvulus
W. bancrofti zones
O. volvulus zones
Filaria presence 
         
Figure 2 Micro-stratification of historical data on filarial disease co-endemicity a) Mayombe, Bas Congo b) Bandundu (Banningville),
Bandundu c) Tshuapa (Cuvette Centrale), Équateur.
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Page 7 of 13that high prevalence areas occur in Bas Congo, Ban-
dundu, Équateur and Oriental Provinces, and frequently
associated with the Congo River and its tributaries
(Table 1; Figures 1, 2a-c). This broadly contrasts to high
prevalence L. loa distribution, which predominantly
occurs in the Oriental Province and areas of Bas Congo,
Équateur and Maniema Provinces, and closely associated
with tropical dense forests.
On a finer scale, the studies that examined both filaria
diseases in sufficient detail [44,45,47,48], suggest that LF
and loiasis distributions differ at a micro level. For exam-
ple, Henrard et al. [44] found more cases of W. bancrofti
in Matadi, and Bandundu regions than L. loa,b u tm o r e
cases of L.loa in the Kinshasa, Mbandaka (Coquilhatville),
Thysville and Luozi regions than W. bancrofti.T h e
reproduction of historical maps and filaria data points
from the Mayombe [48], Bandundu (Banningville) [47],
and Tshuapa (Cuvette Centrale) [45] further highlight
the geographical differences and the localised overlaps
between the diseases, (Figures 2a-c). In the forested
region of Mayombe and river region of Tshuapa, L. loa
was most prevalent with only one or two locations
reporting both diseases [45,48]. In the river region of
Bandundu, W. bancrofti was most prevalent in villages
bordering the river with no overlap with L. loa,w h i c h
was found in inland villages [47]. Onchocerciasis was also
recorded in these studies [45,47,48], and included in the
maps to highlight the different co-endemic combinations
and the implications of ivermectin treatment.
Risks and benefits of interventions
The onchocerciasis control programme (APOC) CDTi
priority areas are shown in Figure 4a [36], and illustrate
that large areas in the central and northern region of the
country are being targeted with ivermectin treatment.
The potential risks associated with ivermectin treatment
for O.volvulus in potential areas of W.bancrofti and high
L.loa co-endemicity are concentrated in the Oriental
a)  Loa loa 1910-70s                                                                                                  b) Loa loa 2004-2010
c) Vectors 1910-70s d) Overlap
Chrysopsdimidiata
Chrysopssilacea
>40%
20-40%
5-20%
<5%
High prevalence
Low to average prevalence
Localised cases
Non-endemic / no reports
Figure 3 Distribution of a) Loa loa 1910 -70s b) Loa loa 2004-2010 c) Vectors 1910-1970s d) Overlap of Loa loa 2004-2010 and
Vectors 1910-70s.
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Page 8 of 13Province and areas of the northern Équateur Province
(Figure 4b). The potential areas to benefit are extensive
and include large areas of Équateur and Kasai-Oriental
Provinces and areas of the Oriental, Kasai-Occidental
and Bas Congo Provinces (Figure 4c).
The STH recommended treatment areas are shown in
Figure 4d [16], and illustrate that most of DRC is
recommended for either once yearly or twice yearly
albendazole (or mebendazole) treatment. The risks asso-
ciated with the STHs treatment are minimal but may be
related to treatment only recommended once yearly in
potential W.bancrofti and high L.loa co-endemic areas
(Figure 4e). The potential benefits of STH treatment are
again extensive and include large areas of Équateur and
d)   STH recommended treatment e) Risks – once yearly treatment                   f) Benefits - large areas overlapping
once yearly                twice yearly                                               in LF  and Loa loa >40% areas                              with ivermectin treatment
mass treatment unnecessary /undefined
a)     CDTi priority areas                                         b) Risks  - SAEs in potential c). Benefits – ivermectin in
Ivermectin treatment LF and Loa loa >40% areas low–average LF areas
g) Bednet /  ITN ownership h) Risks - Low % of nets / ITNs        i) Benefits – higher % net/ITNs
<35%   in potentialLF and Loaloa >40% areas                     in high prevalence LF areas
>35% 
Figure 4 Interventions distribution maps and associated risks and benefits a) CDTi priority areas b) Risk of CDTi c) benefits of CDTi d)
STH recommended treatment e) Risks of STH treatment f) Benefits of STH treatment g) Bed net /ITN ownership h) Risks of bed net/
ITNs i) Benefits of bed net /ITNs.
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Page 9 of 13Kasai-Oriental Provinces and areas of the Oriental,
Kasai-Occidental and Bas Congo Provinces recom-
mended for twice yearly albendazole (Figure 4f).
The distribution of households owning > 35% ITNs
and/or > 35% bed nets (treated or untreated) is shown
in Figure 4g [30,31], and illustrates that the highest cov-
erage rates occur in Kinshasa, Bas Congo, Katanga,
Maniema, and Sud-Kivu Provinces. The overall percen-
tages for each Province are shown in Table 2 [31]. The
main risk associated with bed net and ITN distribution
is the low coverage in potentially high risk W.bancrofti
areas such as Bandundu Province, and in areas co-ende-
mic with high L.loa, such as the Oriental Province and
areas of northern Équateur Province (Figure 4h). The
benefits include higher coverage rates in the potentially
high risk W. bancrofti areas in Bas Congo (Figure 4i).
Discussion
This study highlights the lack of detailed and current
data on the distribution of LF in DRC, a country consid-
ered to have one of the largest burdens of disease in the
world, and second in sub-Saharan Africa, after Nigeria
[1]. The national LF Programme in DRC is yet to com-
mence MDA implementation, which is complicated by
approximately one third of the country being endemic
for loiasis [9]; a contraindication for any MDA regimen
which includes ivermectin. The reason for the lack of
information and action may be attributed to the wide-
spread civil unrest affecting many parts of the country
for decades, which has left it severely under-resourced in
public and private sectors, as well as the absence of effi-
cient transports systems making access to many areas of
the country difficult [29,32].
The insidious nature of internal instability is a major
barrier for disease control programmes, and has implica-
tions for the national LF programme in terms of acces-
sing remote, rural endemic regions, readily and safely
[32,53]. These problems are not unique to DRC as many
of 16 countries still to start MDA in Africa are loiasis
endemic and considered to be conflict or post-conflict
countries [54]. This group of countries are among the
poorest and most fragile in the world [6], which raises
the importance of an integrated effort between interna-
tional partners, and the various national NTD [8,16,36]
and vector control programmes [19,55] to ensure that
resources are maximised, and the elimination of these
diseases achieved collectively.
The review and mapping of historical data in DRC
highlights gaps in our knowledge and the difficulties in
fully defining the problem. The value of collating and
analysing disparate data sources cannot be underesti-
mated. This activity is recommended for countries plan-
ning to start MDA, as it will help to identify high risk
areas and key risk factors that are crucial to control
efforts even if resources are limited. We also advocate
that the new mapping approach of MOM is essential in
countries where there is co-endemic loiasis as well as
other control programmes which impact on LF imple-
mentation. However, it may be important to evaluate if
transmission is still ongoing in some areas where CDTi
or deworming activities have taken place for several
years, since reported coverage may not always be true
or may not always have the predicted impact on the tar-
geted diseases. Therefore, before excluding an area for
LF control, it may be prudent to rapidly assess the
impact of other interventions on the LF endemicity.
The simple reproduction and overlapping of historical
data and maps, clearly shows the close association of LF
distribution with the Congo River and its tributaries in dif-
ferent regions of the country. This provides key informa-
tion about the ecology and transmission of W. bancrofti
vectors, which is important in DRC where only one study
has been carried out in the past 70 years [44]. In Matadi,
Bas Congo, An. funestus was identified as the most impor-
tant vector of W. bancrofti [44], however, other entomol-
ogy studies indicate a diverse range of Anopheles across
the country [56-58]. An extensive survey found An. mou-
cheti and An. wellcomi most abundant along the central
Congo River system, and An. paludis in the surrounding
hinterland [59]. In Katanga, the mosquito species were
considered to be distinct to other ecological regions [56],
and in the forested Mayombe region, Bas Congo, An. gam-
baie s . lw a sf o u n dt ob em u c hm o r ea b u n d a n tt h a nAn.
funestus and An. moucheti [60], which may explain the
lack of LF found in this region by Fain [48].
The recent maps on the distribution of L. loa in Africa
[ 9 , 2 7 ]a r eau s e f u lr e s o u r c ef o rt h en a t i o n a lL Fp r o -
gramme in DRC. The L. loa maps elucidate SAEs risk
areas, where extra precautions and alternative interven-
tion strategies may be required, especially if LF is found
to be endemic. Comparisons between the historical and
current L. loa maps indicate that its distribution has
Table 2 Percentage of households owning a mosquito
bed net or ITN by Province
Province Bed net ITN
Kinshasa 42.2 25.7
Bas-Congo 55.6 42.0
Bandundu 28.2 19.8
Équateur 31.1 9.3
Orientale 13.1 6.8
Nord-Kivu 13.3 8.2
Maniema 32.4 22.3
Sud-Kivu 39.5 17.8
Katanga 34.9 16.7
Kasaï-Oriental 14.2 9.6
Kasaï-Occidental 21.3 13.9
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Page 10 of 13remained relatively stable for more than half a century,
and been a long-standing public health problem, parti-
cularly in the Oriental Province. The problem extends
across large areas of central Africa affecting many vul-
nerable people [9], and poses a major obstacle to the LF
and onchocerciasis elimination programmes in Africa.
Whilst L. loa is not included in the list of WHO’s1 7
NTDs [61] its importance as an impediment to progress
of programmes based on preventive chemotherapy can-
not be understated.
Overlapping the C. silacea and C. dimidiata distribu-
tion data with the L. loa map indicates that both vectors
may transmit the infection in the high risk areas. In Cen-
tral Africa these Chrysops sp are found to be sympatric in
tropical rain forests and rubber plantations, and shown
to bite throughout the day and have different annual
transmission cycles [26,28]. To eliminate LF in rain forest
loiasis co-endemic areas will require new innovative stra-
tegies, possibly including Chrysops control as a novel
approach. Although the development of villages, clearing
of vegetation and the spraying of insecticides of Chrysops
breeding sites have shown to produce a degree of control
of loiasis transmission [62-65], these methods are
impractical. Therefore, it may better to use impregnated/
baited traps or trapping methods similar to those used
for Human African Trypansomiasis (HAT), which is
transmitted by Glossina but shares some biological fea-
tures of Chrysops biting patterns and habitats [66].
Recent data shown in the global atlas of HAT indicates
geographical overlap in some high risk L. loa areas, and
the use of MOM may elucidate areas where both vectors
may be trapped for control purposes.
Alternatively, a combination of new drug regimens and
integrated vector management (IVM) [67] may be an
option in high risk LF areas and co-endemic high loiasis
areas. The use of alternative drug strategies such as twice
yearly treatment or higher doses of albendazole [15] or 4-
6 week course of doxycycline [68] may be a better
approach to reduce filaria loads, and reduce the risk of
disease and SAEs in selected populations. These alterna-
tive drug strategies used in combination with ITN/LLINs
and/ or indoor residual spraying (IRS) may also signifi-
cantly reduce W. bancrofti transmission [19]. More
synergies between malaria and LF programmes are essen-
tial, especially as the distribution of ITN/LLINs is
increasing dramatically. Although no large-scale IRS
activity is planned for DRC [55], historical IRS activities
using gammexane, show considerable reductions in An.
moucheti, An. gambiae s.l and An. paludis densities in
DRC [69], and more recently with DDT in An. funestus
in other countries [70], which suggests that IRS could be
targeted with significant impact, especially in Oriental
Province. However, it will be important to monitor insec-
ticide resistance of vector control activities [70,71].
The extent to which W. bancrofti and O.volvulus over-
lap in L.loa > 40% high risk areas in Oriental Province is
unknown, however, Woodman [72] in neighbouring
southern Sudan illustrates that the three diseases are co-
endemic across relatively large geographical areas. The
use of MOM could elucidate different patterns of co-
endemicity within such areas, to determine if certain
interventions would be of risk or benefit. The three finer
scale maps in this study show that different regions have
different spatial and overlapping patterns with different
risks and benefits. For example, in the Mayombe region,
Bas Congo [48]L. loa was most prevalent, and only over-
lapped with W.bancrofti and O.volvulus in distinct areas.
This region has high bed net/ITN coverage, which is of
significant benefit; however, the overlap of the CDTi
priority area in the L.loa and O.volvulus co-endemic area
is a risk as ivermectin treatment could result in SAEs. In
contrast, in the Bandundu (Banningville) region [47], the
overlaps between the CDTI priority areas and W. ban-
crofti and O.volvulus co-endemic areas will be of consid-
erable benefit as ivermectin could reduce the prevalence
of both diseases (as well as STHs) along the river with
limited risk of SAEs. However, there is a low or no cover-
age of bed nets/ITNs in this region [30,31].
On a broader scale, the country level maps highlighting
the overlaps between different disease distributions and
interventions provide important insights into the poten-
tial risks and benefits of multiple large-scale disease con-
trol programmes operating in one country. It clearly
identifies high risk and vulnerable populations which
need to be targeted with more effective or alternative
innovative intervention strategies. Importantly, it also
shows the potential large-scale benefits that the combina-
tion of the onchocerciasis, malaria, and future STH pro-
grammes could provide to the national LF programme
and vice versa. Clearly, there are huge benefits of coordi-
nated and overlapping mapping activities so Ministries of
Health have a clear picture of the epidemiology for plan-
ning purposes.
Conclusions
This paper identifies a new approach to mapping that
takes account of factors that will influence country LF
elimination strategies and plans. The paper suggests that
country plans require higher resolution mapping that has
been used to date, before implementation of LF activities
can be efficiently deployed. This is because 1) distribution
of ivermectin through APOC projects will already have
had an impact of LF intensity and prevalence 2) DRC as
an example, has been up scaling bed net /ITN distribution
which will impact over time on transmission of W. ban-
crofti and 3) recently available predictive maps of L. loa
allow higher risk areas to be identified. This will allow LF
implementation to be initiated with reduced risk where
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Page 11 of 13L. loa is considered non-endemic. We believe that using
the proposed MOM approach is a prerequisite for plan-
ning the expanded distribution of drugs for LF pro-
grammes in countries co-endemic for filarial infections.
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